课题基金 / 基金详情

PATHOGENESIS OF GROUND GLASS CELLS IN HEPATITIS B

PATHOGENESIS OF GROUND GLASS CELLS IN HEPATITIS B
乙型肝炎中毛玻璃细胞的发病机制
批准号:
3200075
负责人:
Tien-Sze Benedict Yen
金额:
$14.25万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-03-05 至 1995-02-28

项目摘要

项目成果

Tien-Sze Benedict Yen的其他基金

相似基金

相关文献

中文摘要
翻译
乙型肝炎病毒(HBV)与肝细胞性肝炎明显相关
英文摘要
Hepatitis B virus (HBV) is clearly associated with hepatocellular carcinomas, yet the mechanism of carcinogenesis is poorly understood. One possibility, strengthened by recent transgenic mouse studies, is that cellular necrosis and regeneration contribute significantly to carcinogenesis. In chronic HBV infection, there is appearance of so-called ground glass cells, which are cells with inspissated HBV surface proteins in the endoplasmic reticulum. Ground glass cells in transgenic mice can cause sufficient cellular damage and hepatic regeneration to induce hepatocellular carcinomas. Therefore, we would like to investigate how ground glass cells are produced in human infections. Our hypothesis is that genomic rearrangements of the HBV DNA, almost invariably present during chronic infection, cause dys-regulated transcription of the viral surface gene. This, in turn, leads to over synthesis of the large form of the surface protein, which is known to be capable of causing ground glass cells. We will test our hypothesis by generating mutant HBV clones, and looking for surface gene dys-regulation by transient transfections. We will further confirm that these mutations can cause ground glass cells in cultured cells and transgenic mice. It is hoped that these studies will lead to new insights on the pathogenesis of ground glass cells, and ultimately of hepatocellular carcinoma in HBV infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New mouse model of hepatitis B virus-associated hepatocellular carcinoma
HEPATIC CARCINOGENESIS INDUCED BY HEPATITIS B VIRUS PreS2 MUTANT
  • 批准号:
    7246015
  • 项目类别:
  • 资助金额:
    $47.51万
  • 财政年份:
    2007
  • 负责人:
    Tien-Sze Benedict Yen
  • 依托单位:
PreS2 Mutant of Hepatitis B Virus as Early Marker of Hepatocellular Carcinoma
PreS2 Mutant of Hepatitis B Virus as Early Marker of Hepatocellular Carcinoma
海外基金